华森制药(002907.SZ)：公司药品生产许可证变更

Core Viewpoint - Huason Pharmaceutical (002907.SZ) has received a new drug production license from the Chongqing Municipal Drug Administration, which includes changes in entrusted production for the drug Empagliflozin tablets [1] Group 1: License Details - The license number issued is 渝20150018, which involves a reduction in entrusted production limited to drug registration applications [1] - The entrusted production reduction is for Empagliflozin tablets (10mg, 25mg) with the client being Youhua Pharmaceutical Technology Co., Ltd., and the production site located at No. 143, Banqiao Road, Changzhou Street, Rongchang District, Chongqing, valid until November 9, 2025 [1] - Additionally, there is new entrusted production for Empagliflozin tablets (National Drug Approval Numbers H20255257, H20255258) with the same client and production site, valid until March 2, 2026 [1]